Combined Surgical Approach to Carotid and Coronary Artery Disease by Cristijan Bulat et al.
Coll. Antropol. 32 (2008) 1: 209–216
Original scientific paper
Combined Surgical Approach to Carotid
and Coronary Artery Disease
Cristijan Bulat, Igor Alfirevi}, Zvonimir Ante Korda, Nenad Protrka,
Mladen Novkoski and Mladen Predrijevac
Department of Cardiovascular Surgery, Special Hospital for Cardiovascular Surgery and Cardiology »Magdalena«,
Krapinske Toplice, Croatia
A B S T R A C T
The aim of this study was to compare two different surgical approaches to patients with coexistent significant carotid
and coronary artery obstruction. Patients were treated with combined operation of carotid endarterectomy and coronary
artery bypass grafting (CEA/CABG). The first group of patients underwent the CABG procedure with the cardiopul-
monary bypass (CPB) on arrested heart and the second group without the CPB on a beating heart – off pump. Between
May 15 1998, and October 9 2003, thirty-five consecutive patients underwent the combined procedure. In both groups
there were no cases of transient or permanent perioperative neurological events. Overall, early mortality was 5.6%. The
incidence of a perioperative myocardial infarction was 5.5%. In the follow-up period there were no cases of late stroke.
According to the presented results in this study, it was found that the combined CEA and CABG is an equally safe and ef-
fective procedure performed with or without cardiopulmonary bypass for patients with a severe coexistent carotid and
coronary artery disease.
Key words: carotid artery obstruction, carotid endarterectomy, coronary artery obstruction, coronary artery bypass
grafting, stroke
Introduction
The presence of a significant carotid artery disease in
patients requiring coronary artery bypass grafting
(CABG), incidentally found during a preparation for sur-
gery, still is a matter of debate concerning the best surgi-
cal management. The incidence of more than 80% ca-
rotid artery stenosis in patients undergoing elective
CABG has been reported as 8.5%1,2. Even a higher inci-
dence of carotid artery stenosis has been reported with
the left main coronary artery disease3.
There is no ideal method to treat this high-risk group
of patients. Options vary from a simultaneous (same an-
esthesia) to a staged procedure, whereby carotid endarte-
rectomy (CEA) is performed several days prior to (staged
approach) or after (reversed staged approach) coronary
revascularisation. Each of these methods has its advan-
tages and disadvantages, which can be measured by
global mortality, incidence of stroke and incidence of
myocardial infarction (MI).
Advocates of combined approach (simultaneous the
CEA and CABG procedure) cite low incidence of stroke
and MI as well as cost benefits of that procedure4–11. The
rate of permanent neurological deficit was 1.9–9% and
the mortality rate 3–8%4,8,10–13.
In an effort to reduce the incidence of perioperative
neurological complication among the high-risk patients
with the coexistent critical carotid and coronary artery
disease, we have approached these patients in our insti-
tution with combined procedure in which the CEA pre-
ceded the CABG during the same anesthesia.
The cardiopulmonary bypass (CPB) has been repor-
ted to be associated with a higher risk of stroke14,15. The
off pump CABG (OPCABG) avoids the CPB as one of the
contributing factors for stroke and gives additional bene-
fits of decreased morbidity from systemic inflammatory
response, in terms of blood loss, use of blood and blood
products, intensive care unit stay, and hospital stay16,17.
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The aim of this study was to compare two different
surgical approaches to patients with the coexistant ca-
rotid and coronary artery obstruction, according to post-
operative results, especially neurological complications.
The CABG was made with the CPB on arrested heart
(CPBCABG) or on a beating heart without the CPB
(OPCABG). The surgical strategy and approach to each
patient depended on the choice of each surgeon.
Relatively little data has been available for the long-
term follow-up of combined CEA/CABG patients.
In this study, we also tried to determine the long-term
results in these patients treated with the combined CEA/
CABG operations, especially the late survival and free-
dom from late stroke.
Materials and Methods
Patients
Between May 15, 1998, and October 9, 2003, thirty-
five consecutive patients underwent combined carotid
and coronary artery revascularisation, representing 2%
of all coronary operations performed in our institution
during this period. The data was retrospectively review-
ed for demographic information, clinical, angiographic
and operative characteristics and results.
The distribution of important demographic and clini-
cal characteristics of patients is shown in Table 1.
The average age of the CPBCABG group of patients
was 65.355.65 years (range 55 to 74 years), and of the
OPCABG group of patients was 63.946.58 years (range
50 to 76 years), (p=0.502, Table 1).
There were 15 men (88%) and 2 woman (12%) in the
first group of patients, versus 14 men (77%) and 4
woman (22%) in the second group of patients.
The male-to-female ratio in two observed groups did
not differ significantly (p=0.658, Table 1).
Symptoms related to coronary artery disease, as exer-
tion angina, unstable angina and prior myocardial in-
farction in two observed groups did not differ signifi-
cantly (p=1.000, Table 1).
The relative frequencies of asymptomatic bruit, tran-
sient ischemic attack (TIA), prior stroke and prior CEA
in the neurological history in two observed groups did
not differ significantly (p=0.228, Table 1).
Preoperative screening
Nearly all patients in this study were referred to hos-
pital because of cardiac symptoms. Non-invasive carotid
artery testing was performed on all patients with or
without a history of neurological symptoms, a previous
stroke, audible carotid bruit or evidence of multisystem
vascular disease.
Extracranial carotid arteries were evaluated by color
flow duplex scanning study. B-mode and color flow im-
ages of the common, external, and internal carotid arter-
ies were obtained in longitudinal and transverse planes.
The presence of plaque was noted and reduction in the
cross-sectional area of the lumen was calculated. Pa-
tients who had more than or equal to 70% narrowing of
common or internal carotid artery underwent a selective
carotid angiography. A haemodynamically significant le-
sion was defined as a diameter reduction of equal or more
than 70% of internal carotid artery (ICA) relative to the
normal distal ICA.
The absolute indications for simultaneous procedures
were symptomatic carotid artery disease (defined as ei-
ther a TIA or a stroke occurring four or more weeks be-
fore the CABG), ICA stenosis of 70% or more, with or
without a contralateral disease (the CEA was performed
on the more severely affected side, unless stenosis of
100% – occluded) and ulcerated, unstable ICA lesion, re-
gardless of the degree of stenosis.
Patients with the carotid stenosis of less than 70%
were treated no differently from patients without steno-
sis.
The findings of coronary angiographic and carotid
color flow duplex scanning/angiographic features in the
patients’ population are listed in Table 2.
A three-vessel coronary disease or a significant left
main disease (more than 50% stenosis), or both, were
present in 81% of the first group of patients and 77% in
the second group of patients. The relative frequencies of
coronary angiography findings in two observed groups
did not differ significantly (p=1.000, Table 2).
The mean values of relative ICA stenosis on operated
side did not differ significantly (p=0.301, Table 2). Con-
tra lateral disease did not differ significantly (p=0.711,
Table 2).
Definitions
Preoperative neurological status was categorized as
asymptomatic or symptomatic (history of TIA, amaurosis
fugax or complete stroke).
Perioperative neurological events were defined as TIA,
reversible ischemic neurological deficit, or complete stroke.
Perioperative MI was defined as the occurrence of
new Q waves, persistent ST segment changes correlated
with an elevated myocardial fraction of creatinine kina-
ze, or new wall motion abnormality on echocardiogram.
Operative technique
All patients underwent one CEA and CABG, per-
formed concomitantly under general anesthesia by the
same operating team. All the CEAs were performed be-
fore myocardial revascularisation regardless if it was
made with or without the CPB.
The CEA was made in the usual fashion, by ventral
incision anterior to sternocleidomastoid muscle. Patients
were heparinized by 5,000 i.u. of heparin. The decision to
use a shunt or not was based on collateral circulation
(back flow in the internal carotid artery). A shunt was
used in all cases with occlusion of contralateral carotid
artery. Arteriotomy was closed directly using a running
6–0 non-absorbable suture. The wound was closed after
myocardial revascularisation with drainage.
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The median sternotomy was performed after the CEA.
The initial heparin dose (after internal mammary artery
harvesting) was given depending on base line activated
clotting time (ACT) obtained after completion of the
CEA. The ACT was maintained longer then 480 seconds
in the CPBCABG procedure or 250 seconds in the OPCABG
procedure. Conversion of heparin was made by 3 mg per
kg of protamin sulfate at the end of procedure. Standard
CABG was performed with the CPB on 17 patients (48%)
and without the CPB on 18 patients (52%).
In those patients with the CPBCABG, the mean arte-
rial pressure was maintained at a minimum of 60 mmHg.
The CPB was normothermic in all patients. The ascend-
ing aorta, aortic arch, and descending aorta were exam-
ined for presence of significant atherosclerotic disease
(mobile atheroma, wall thickening, etc.) using routinely
transesophageal and epiaortic echocardiography. When
significant aortic disease was found, at the discretion of
the operating surgeon, the aorta was not used for the cre-
ation of proximal anastomoses. In cases in which the
aorta was used, great efforts were made to use a single
partial aortic occlusion period with a side-biting clamp in
an area of ascending aorta deemed to be free of athero-
sclerotic disease. In order to see the global and regional
left ventricular functions in all patients, the transeso-
phageal echocardiography was performed before, during
and after the operation.
The OPCABG was performed through a midsterno-
tomy using stabilization devices and an oxygen blower
was used for providing a bloodless field.
Follow-up
A follow-up clinical information about survival and
subsequent neurological and coronary events was ob-
tained during the period of hospitalization, and 3 to 68
months postoperatively (average 10.916.3 months) through
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TABLE 1








X± SD 65.35±5.65 63.94±6.58 ns
Range 55–74 50–76
=70years 3 (18) 3 (16) ns
Sex
Male 15 (88) 14 (77) ns
Female 2 (12) 4 (22) ns
Smoking history 13 (76) 14 (77) ns
Hypertension 12 (70) 16 (88) ns
Diabetes mellitus 5 (29) 4 (22) ns
Renal insufficiency 0 1 (5) *
Chronic obstructive pulmonary disease 3 (17) 4 (22) ns
Cardiac history
Asymptomatic 1 (5) 0 *
Exertion angina 12 (70) 13 (72) ns
Unstable angina 4 (23) 5 (27) ns
Prior myocardial infarction 6 (35) 6 (33) ns
Prior coronary artery bypass grafting 0 0
Left ventricular ejection fraction
X±SD 61.17±6.96 56.11±9.93 ns
Ejection fraction =35% 0 2 (11) *
Neurologic history
Asymptomatic bruit 12 (70) 16 (88) ns
Transient ischemic attack 5 (29) 2 (11) ns
Prior stroke 2 (12) 3 (16) ns
Prior carotid endarterectomy 1 (5) 1 (5) ns
Euroscore
X± SD 5.35±2.57 6.05±2.01 ns
Numbers in parenthesis are percentages, *The frequencies are too low for statistical analysis, CPBCABG – cardiopulmonary bypass
coronary artery bypass grafting, OPCABG – off pump coronary artery bypass grafting
direct communication with patients. Neurological and
cardiac status was evaluated.
Statistical analysis
The interval values were expressed as mean values 
standard deviation and compared using the t-test. The
categorical data were analyzed using the ÷2 test or Fi-
scher’s exact test. It was significant that the p value was
lower than 0.05.
Results
The operative characteristics of the CEA and the
CABG procedures are listed in Table 3 and 4.
All patients had a unilateral CEA. A right CEA was
performed in 10 (58%) cases, versus 12 (66%) cases, and a
left CEA was performed in 7 (41%) cases, vs. 6 (33%)
cases (p=0.733, Table 3). None underwent bilateral ca-
rotid endarterectomy or had prior contralateral CEA.
The carotid arteriotomy was closed directly in all pa-
tients. A shunt was used in 10 (58%), vs. 6 (33%) cases.
The mean carotid occlusion time in two observed groups
did not differ significantly (p=0.439, Table 3).
The CPBCABG was performed in 17 patients and the
OPCABG in 18 patients. The CPB was maintained for a
mean of 87.1726.09 minutes. The average aortic cross-
clamp time was 52.1717.1 minutes.
On average, 3.71.04 coronary artery bypass grafts
were performed in the CPBCABG group of patients
(range 3 to 6 grafts) and 1.830.78 coronary artery by-
pass grafts in the OPCABG group of patients (range 1 to
4 grafts). The mean number of grafts applied was signifi-
cantly greater in the CPBCABG than in the OPCABG
patients (t=6.041, p=0.000, Table 4). In 14 (82%) vs. 18
(100%) cases the left internal mammary artery was used
(p=0.104, Table 4).
The incidence of in-hospital and 30-day postoperative
events is listed in Table 5.
Briefly, there were no cases of perioperative perma-
nent and transient stroke or other neurological events in
both groups of the patients. In the CPBCABG group
there was neither a perioperative death nor MI.
The incidence of a perioperative death was 11% (2 of
18) in the OPCABG group, including one case of intra-
operative MI (5.5%).
The primary cause of death in the two CEA/OPCABG
patients was as follows: the first was due to an intraope-
rative MI, the second was due to perioperative pulmo-
nary embolism on the fourth postoperative day. In the
first case, the electrocardiogram abnormalities, the car-
diac enzymes and the transesophageal echocardiography
determined the MI. The second case was determined by
autopsy findings.
One of the CPBCABG patients and one of the OPCABG
have developed a neck haematoma, which requested re-
exploration and evacuation of the haematoma (p=1.000,
Table 5). There was no infection at the CEA site.











One vessel disease 1 (5.6) 1 (5.5) ns
Double vessel disease 2 (11) 3 (16) ns
Triple vessel disease 9 (52) 8 (44) ns
Left main stenosis 5 (29) 6 (33) ns
Left ventricular ejection fraction
Normal (>50) 15 (88) 15 (83) ns
Mildly depressed (41–50) 2 (11) 1 (5.5) ns
Moderately depressed (31–40) 0 2 (11) *
Severely depressed (<30) 0 0
ICA % stenosis on operated side
X±SD 80.82%±10.96% 77.5%±7.52% ns
Range 70–99% 70–95%
Contralateral stenosis 12 (71) 14 (77) ns
ICA % stenosis on nonoperated side
X±SD 72.91%±22.6% 69.3%±17.6% ns
Range 50–100% 50–100%
Total occlusion 4 (23) 3 (16) ns
Numbers in parenthesis are percentages, *The frequencies are too low for statistical analysis, CPBCABG – cardiopulmonary bypass
coronary artery bypass grafting, OPCABG – off pump coronary artery bypass grafting, ICA – internal carotid artery
The average pulmonary ventilation in the first group
of patients was 18.24.67 hours (with the range of 7 to 24
hours), versus 13.935.7 hours (with the range of 8 to 24
hours) in the second group of patients, and was signifi-
cantly higher in the CPBCABG than in the OPCABG pa-
tients (p=0.021, Table 5).
An average postoperative intensive care unit stay was
3.815.92 days, with the range of 2 to 11 days, vs. 3.29
3.8 days with the range of 1 to 16 days. The mean and up
to seven days long intensive care unit stay in two ob-
served groups did not differ significantly (p=0.758, p=
0.177, Table 5).
An average length of postoperative hospitalization
was 11.757.78 days, with the range of 5 to 32 days, vs.
10.326.52 days, with the range of 5 to 58 days and did
not differ significantly in two observed groups (p=0.534,
Table 5).
With two cases of death in the perioperative period,
17 patients in the CEA/CPBCABG group and 16 patients
in the CEA/OPCABG group were available for a long-
term follow-up, listed in Table 6.
The average follow-up was 10.916.3 months (with
the range of 3 to 68 months). During the follow-up pe-
riod, there were no cases of late stroke and mortality in
the CPBCABG group, or in the OPCABG group.
Discussion
The initial premise in this study was that the CEA
and the CABG are the best treatment modalities for pa-
tients with a significant carotid or coronary disease18–23.
Controversies existed in literature whether or not the
CEA is protective against a stroke. However, some ran-
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TABLE 4








XSD 3.7±1.04 1.83±0.78 <0.001
Range 3–6 1–4
Left internal mammary artery 14 (82) 18 (100) ns








Preoperative 1 (5) 1 (5) ns
Intraoperative 0 1 (5) *
Postoperative 0 0
Numbers in parenthesis are percentages, *The frequencies are too low for statistical analysis, CPBCABG – cardiopulmonary bypass
coronary artery bypass grafting, OPCABG – off pump coronary artery bypass grafting
TABLE 3







Right carotid endarterectomy 10 (58) 12 (66) ns
Left carotid endarterectomy 7 (41) 6 (33) ns
Bilateral carotid endarterectomy 0 0
Shunt used 10 (58) 6 (33) ns
Carotid occlusion time – minutes
X±SD 17±2.23 17.75±3.3 ns
Numbers in parenthesis are percentages, CPBCABG – cardiopulmonary bypass coronary artery bypass grafting, OPCABG – off pump
coronary artery bypass grafting
domized trials have demonstrated a significant benefit of
the CEA over a continuous medical treatment for symp-
tomatic patients with reduction of ipsilaterale stroke
from 26% to 9%24, and even for asymptomatic severe ca-
rotid artery stenosis with reduction in ipsilateral neuro-
logical events from 18% to 7%25. These data may be ex-
trapolated to the patients requiring the CABG, and argue
our aggressive surgical approach for this population.
The second premise that had to be addressed was
whether the presence of a severe disease in one arterial
system could be a significant threat to patients with the
coexistent diseases if an operation addresses only the dis-
ease in the other system.
The major contribution of the coronary artery disease
to the short-term risks of the CEA has been well esta-
blished26. The CEA done in patients with a severe uncor-
rected coronary artery disease has been associated with
perioperative MI rates as high as 17% and operative mor-
tality rates of up to 20%, with MI accounting for as many
as 60% of these deaths7,8.
The incidence of neurological complications that oc-
cured during the performance of coronary artery surgery











Transient ischemic attack 0 1 (6.6) *
Stroke 0 0
Cardiac related events
Exertion angina 1 (6.6) 1 (6.6) ns
Unstable angina 0 0
Congestive heart failure 0 0
Myocardial infarction 0 0
Numbers in parenthesis are percentages, *The frequencies are too low for statistical analysis, CPBCABG – cardiopulmonary bypass
coronary artery bypass grafting, OPCABG – off pump coronary artery bypass grafting
TABLE 5







Death (hospital/30-day) 0 2 (11) *
Myocardial infarction 0 1 (5.5) *
Pulmonary embolism 0 1 (5.5) *
Pulmonary ventilation – hours
X±SD 18.2±4.67 13.93±5.7 <0.05
Range 7–24 8–24
Reexploration for neck wound bleeding 1 (5) 1 (5) ns
Neck wound infection 0 0
Transient ischaemic attacks 0 0
Stroke 0 0
Combined total stroke and death 0 0
Intensive care unit stay – days
X±SD 3.81±5.92 3.29±3.8 ns
Range 2–11 1–16
<7 days 13 (76) 17 (94) ns
Hospital stay – days
X±SD 11.75±7.78 10.23±6.52 ns
Range 5–32 5–58
Numbers in parenthesis are percentages, *The frequencies are too low for statistical analysis, CPBCABG – cardiopulmonary bypass
coronary artery bypass grafting, OPCABG – off pump coronary artery bypass grafting
varies widely and has been reported between 1 and
14%8,9,12,27. Although the role of carotid disease in the
genesis of perioperative stroke in patients undergoing
isolated myocardial revascularisation remains incomple-
tely defined, because of multifactorial etiology, several
reports indicate that significant carotid artery stenosis is
an important, and for some the strongest, incremental
risk factor4–6. D’Agostino at al., estimated perioperative
risk at <2% in patients with carotid stenosis <50%, 10%
with stenosis 50–80%, and 11–19% with stenosis >80%13.
A risk for the perioperative stroke after the CABG has
become an issue of increasing importance to cardiac sur-
geons, especially as the average age of coronary bypass
patients continues to rise as well as the incidence of the
stroke. Tuman and colleagues reported a stroke rate of
0.9% for patients who were less than 65 years old com-
pared with 8.9% for patients who were more than 75
years of age, with the curve of stroke incidence in their
patients rising exponentially after the age of 6528. To put
this risk in perspective, the average age of coronary by-
pass patients in our institution is currently 618.87
years (the range of 18 to 88 years), with 4.7% of patients
being 75 or more years of age.
The third premise was that the combined CEA de-
creases the incidence of stroke, severity of stroke, or
mortality at the time of the CABG compared with stage
procedure.
Hertzer and colleagues compared results from com-
bined and staged patients and found a lower stroke inci-
dence (5.3% versus 11.4%) and stroke/death (8.4% versus
13.3%) with combined versus staged surgery9. This is
contrary to an earlier report in which both stroke (8.7%
versus 5.1%) and stroke/death (13.0% versus 6.8%) was
greater with combined surgery29.
Takach and associates compared the results of staged
and combined procedure over two periods (1975 to 1985
versus 1986 to 1996). They found a similar trend of in-
creased safety of combined procedure over those two pe-
riods (stroke: 5.4% down to 1.9%; stroke/death: 8.1%
down to 5.7%)30.
Brener and associates concluded that a superior out-
come could be achieved with the combined operation31.
The reports of other authors have also demonstrated the
safety and efficacy of the simultaneous CEA and CABG10,
11,32,33.
A therapeutic and technical advances of contempo-
rary cardiac surgery, operative myocardial protection,
hemodynamic stability, patient monitoring, and medical
management have been important factors contributing
to the increased safety of combined coronary and carotid
artery surgery34–39.
A combined strategy of the CEA and the OPCABG
performed on patients with a severe coexistent carotid
and coronary artery disease, who are at a high risk for a
perioperative stroke, could have several benefits. Firstly,
the risk of embolism from the carotid source is poten-
tially reduced. Secondly, by minimizing aortic manipula-
tion it reduces the chance of atheroembolism from an
aortic source. Thirdly, the OPCABG procedure may elim-
inate some of the potential untoward effects of non-
pulsatile extracorporeal circulation (systemic inflamma-
tory response, low-flow phenomena, etc.)10,40,41.
The key question in this study was whether the si-
multaneous CEA and CABG procedure is equally safe
and efficacious surgical approach if performed with and
without the cardiopulmonary bypass.
In our both groups of patients there was no incidence
of in-hospital ipsilateral permanent neurological sequels,
nor incidence of combined total stroke and death. We be-
lieve that the simultaneous CEA and CABG procedure is
safe and efficacious surgical approach performed with or
without the CPB for patients with a severe coexistent ca-
rotid and coronary artery disease. Results documented in
this study justify our rather aggressive approach we took
on these severely diseased patients.
Long-term results found in patients who require ei-
ther the CEA or the CABG have yielded good results.
Civil et al. reported a 2.2% stroke rate after mean follow-
up of 22 months42. Reported actuarial 5-year rates for
freedom from stroke after the CEA have ranged from 87
to 90%43,44. Long-term survival after the CEA has been
reported with good results. Actuarial 5-year survival af-
ter the CEA has ranged from 72 to 82%45. As a common
cause for late deaths, MI was revealed44.
The five and 10 year survival after the CABG was re-
ported by Meyers and associates to be 90% and 74%46.
In the follow-up period, there were no cases of late
stroke. When comparing long-term results of our both
groups of patients to the CEA patients, both groups enjoy
same benefits of excellent long-term freedom from stroke
and long-term survival. Therefore, we have identified pa-
tients that have benefited from operative strategies that
include both, the carotid artery disease and the coronary
artery disease.
The economic benefit was also reported, avoiding two
separate operative procedures and hospitalization, as
well as presenting substantially prolonged hospital stays
of patients with perioperative cerebrovascular accidents11.
Conclusion
Combined carotid endarterectomy and coronary ar-
tery bypass grafting is a safe and efficacious surgical ap-
proach performed with and without cardiopulmonary by-
pass for patients with a severe coexistent carotid and
coronary artery disease. Results documented in this stu-
dy justify our rather aggressive approach to patients
with a severe coexistent disease. It also potentially elimi-
nates expenses for subsequent hospitalization due to the
second operation, or a stroke resulting from uncorrected
carotid artery disease.
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KOMBINIRANI KIRUR[KI POSTUPAK KOD BOLESTI KAROTIDNIH I KORONARNIH ARTERIJA
S A @ E T A K
Cilj ovog rada bio je usporediti dva razli~ita kirur{ka postupka kod bolesnika s istovremenim zna~ajnim su`enjem
karotidnih i koronarnih arterija. Pacijenti su lije~eni kombinirnom operacijom endarterektomije unutarnje karotidne
arterije i aortokoronarnog premo{tenja. U prvoj skupini bolesnika aortokoronarno premo{tenje je napravljeno uz po-
mo} stroja za izvantijelesni krvotok na zaustavljenom srcu, a u drugoj skupini bez uporabe stroja za izvantijelesni
krvotok na kucaju}em srcu. Od 15. svibnja 1998. godine do 9. listopada 2003. godine, u na{oj ustanovi operirano je
ukupno 35 bolesnika kombiniranim kirur{kim postupkom. U ranom postoperativnom razdoblju u obje skupine boles-
nika nije bilo slu~ajeva novonastalog prolaznog niti trajnog neurolo{kog poreme}aja. Ukupna smrtnost bila je 5,6%, a
u~estalost sr~anog infarkta 5,5%. Tijekom pra}enja bolesnika po otpustu iz bolnice nije bilo slu~ajeva novonastalog
neurolo{kog poreme}aja. S obzirom na prikazane rezultate u ovom radu, utvr|eno je da kombinirana operacija karo-
tidne endarterektomije i aortokoronarnih premo{tenja je podjednako siguran i u~inkovit postupak napravljen uz pomo}
stroja za izvantijelesni krvotok kao i bez njegove uporabe kod navedene skupine bolesnika.
C. Bulat et al.: Combined Carotid and Coronary Surgery, Coll. Antropol. 32 (2008) 1: 209–216
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